GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors
Ontology highlight
ABSTRACT: Background: To understand the transcriptional consequences of a TP53 modulation in the GIST cell context, we treated GIST430 with increasing doses of the MDM2-inhibitor nutlin-3 (racemate).
ORGANISM(S): Homo sapiens
PROVIDER: GSE59841 | GEO | 2014/12/25
SECONDARY ACCESSION(S): PRJNA256344
REPOSITORIES: GEO
ACCESS DATA